Healthcare Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3223 |  RCEL Avita Medical, Inc. - Common Stock | 10.76 USD | +6.85% | +3.36% | +139.11% | +152.58% | 332.77 M USD | ||
| 3229 |  EBS Emergent BioSolutions Inc. Common Stock | 6.47 USD | +4.02% | +9.48% | -12.09% | -39.65% | 331.74 M USD | ||
| 3232 |  SION Sionna Therapeutics, Inc. - Common Stock | 7.31 USD | +13.16% | +19.06% | -84.40% | -81.42% | 330.50 M USD | ||
| 3251 |  IMRX Immuneering Corporation - Class A Common Stock | 5.02 USD | +3.51% | -2.52% | +20.96% | -12.54% | 324.78 M USD | ||
| 3257 |  EMBC Embecta Corp. - Common Stock | 5.69 USD | +8.38% | +16.12% | +53.37% | -60.79% | 322.39 M USD | ||
| 3262 |  SMTI Sanara MedTech Inc. - Common Stock | 34.80 USD | +0.03% | +0.69% | +2.96% | +2.69% | 319.74 M USD | ||
| 3273 |  TLSI TriSalus Life Sciences, Inc. - Common Stock | 5.14 USD | -0.58% | +4.90% | +13.97% | +0.39% | 316.49 M USD | ||
| 3281 |  PYXS Pyxis Oncology, Inc. - Common Stock | 3.75 USD | +9.01% | +15.38% | +38.89% | +188.46% | 312.78 M USD | ||
| 3290 |  MYGN Myriad Genetics, Inc. - Common Stock | 3.23 USD | +1.57% | +3.86% | +12.94% | -60.94% | 308.95 M USD | ||
| 3299 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.17 USD | -9.14% | -21.90% | +13.63% | +26.72% | 307.02 M USD | ||
| 3301 |  TMCI Treace Medical Concepts, Inc. - Common Stock | 4.70 USD | +2.17% | -0.42% | +8.80% | -34.45% | 305.66 M USD | ||
| 3307 |  ALEC Alector, Inc. - Common Stock | 2.72 USD | +13.33% | +11.48% | +80.13% | +3.82% | 303.71 M USD | ||
| 3325 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 4.95 USD | +1.02% | -7.30% | +22.52% | +81.32% | 297.52 M USD | ||
| 3327 |  CV CapsoVision, Inc. - Common Stock | 5.93 USD | +1.02% | +2.24% | -11.62% | +60.70% | 296.78 M USD | ||
| 3336 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.85 USD | -0.52% | -0.26% | +6.06% | -39.47% | 293.74 M USD | ||
| 3337 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.45 USD | +0.82% | -4.30% | +0.82% | +137.86% | 293.56 M USD | ||
| 3342 |  RXST RxSight, Inc. - Common Stock | 7.03 USD | +0.57% | +10.53% | +15.25% | -19.01% | 292.40 M USD | ||
| 3345 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.70 USD | -1.08% | -4.93% | -4.06% | -11.95% | 289.38 M USD | ||
| 3347 |  ACIU AC Immune SA - Common Stock | 2.84 USD | +5.97% | +0.35% | +26.79% | +28.51% | 288.95 M USD | ||
| 3349 |  ANIK Anika Therapeutics Inc. - Common Stock | 21.55 USD | +2.08% | +0.19% | +10.01% | +112.52% | 288.40 M USD |
News Healthcare Stocks
Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia - Slideshow (NASDAQ:ARWR) 2026-09-02
High Tide: German Expansion Just Added Another Bullish Catalyst (NASDAQ:HITI)
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART)
Dow Jones Futures: Snowflake, Broadcom, HPE Are Big Earnings Movers; Tesla Cybercab Event Due
Gainers Healthcare Stocks
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0021 | +2000.00% |
 NTRBW Nutriband Inc. - Warrant | 0.5850 | +67.14% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0699 | +58.50% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.2498 | +49.31% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 9.75 | +47.95% |
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.2200 | +37.50% |
 BFRGW Bullfrog AI Holdings, Inc. - Warrants | 0.0999 | +33.02% |
 CINGW Cingulate Inc. - Warrants | 0.0113 | +24.18% |
Losers Healthcare Stocks
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.38 | -43.28% |
 CDT CDT Equity Inc. - Common Stock | 0.91 | -38.51% |
 CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 2.36 | -27.83% |
 NXGLW NexGel, Inc - Warrant | 0.0123 | -22.64% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.11 | -21.43% |
 APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 2.74 | -20.81% |
 HKPD Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares | 0.15 | -16.67% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.30 | -15.58% |